AMN vs. CHE, RCM, CRVL, AMED, MD, CCRN, LH, DGX, DVA, and RHI
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include Chemed (CHE), R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), and Robert Half (RHI).
AMN Healthcare Services (NYSE:AMN) and Chemed (NYSE:CHE) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, community ranking, profitability and analyst recommendations.
AMN Healthcare Services has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.
AMN Healthcare Services presently has a consensus target price of $75.57, indicating a potential upside of 35.17%. Chemed has a consensus target price of $673.50, indicating a potential upside of 21.31%. Given AMN Healthcare Services' higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Chemed.
Chemed has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.
In the previous week, AMN Healthcare Services had 1 more articles in the media than Chemed. MarketBeat recorded 8 mentions for AMN Healthcare Services and 7 mentions for Chemed. Chemed's average media sentiment score of 0.86 beat AMN Healthcare Services' score of 0.62 indicating that Chemed is being referred to more favorably in the news media.
99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 95.8% of Chemed shares are held by institutional investors. 0.9% of AMN Healthcare Services shares are held by company insiders. Comparatively, 3.3% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
AMN Healthcare Services received 108 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 68.87% of users gave AMN Healthcare Services an outperform vote while only 63.46% of users gave Chemed an outperform vote.
Chemed has a net margin of 12.36% compared to AMN Healthcare Services' net margin of 4.13%. AMN Healthcare Services' return on equity of 31.39% beat Chemed's return on equity.
Summary
Chemed beats AMN Healthcare Services on 10 of the 18 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
